Monroe Capital LLC said April 30 that Alex Patil has joined the firm’s originations team as managing director, West Coast region. Patil was previously a managing director at Medley Management Inc.
2 min read · 30 April 2019
Vividion Therapeutics said April 30 that it raised $82 million in Series B financing led by Nextech Invest. New investors BVF Partners, Casdin Capital, Mubadala Ventures, Trinitas Capital, Mirae Asset Capital, Altitude Life Science Ventures, and Alexandria Venture Investments participated in the round. Existing investors ARCH Venture Partners, Versant Ventures, Cardinal Partners and Celgene Corp also took part. Vividion is a biotech that is developing discover small molecule therapeutics against biologically compelling but previously intractable targets.
3 min read · 30 April 2019
Ablacon Inc said April 30 that it raised $21.5 million in a Series A round led by Ajax Health. Ablacon, of Wheat Ridge, Colorado, has developed an advanced mapping system to guide the treatment of atrial fibrillation.
3 min read · 30 April 2019
Francisco Partners has invested in Perforce Software. Financial terms weren’t announced. Francisco will become an equal partner with Clearlake Capital Group LP, which invested in Perforce in late 2017. Perforce, of Minneapolis, provides enterprise scale software solutions to technology developers and development operations.
4 min read · 30 April 2019
Chewy Inc, the pet retailer majority owned by PetSmart, filed to go public, according to an April 29 SEC filing. Chewy did not disclose how many shares it would sell or their price range. That will come with future filings. The company will trade under the ticker “CHWY” but did not reveal what exchange its shares would trade on, according to the filing. A consortium of PE firm acquired PetSmart in 2015 including BC Partners and Caisse de dépôt et placement du Québec. PetSmart acquired Chewys in 2017 for $3.35 billion.
1 min read · 30 April 2019
Alentis Therapeutics said April 30 that it completed a Series A financing round of 12.5 million swiss francs led by BioMedPartners and BB Pureos Bioventures. BPI France, Schroder Adveq and the German High-Tech Gründerfonds (HTGF) also participated in the round. Alentis is a Swiss-French biotech company developing therapeutics in advanced liver disease and cancer.
3 min read · 30 April 2019
2 min read · 29 April 2019
3 min read · 29 April 2019
Neuberger Berman said April 26 that Patrick Flynn, co-portfolio manager of the Neuberger Berman High Yield Strategies Fund Inc, passed away on April 23. His death was unexpected, a statement said.
3 min read · 29 April 2019
Slack Technologies Inc has filed to go public on the New York Stock Exchange, according to a regulatory filing dated April 26. Slack did not list how many shares it would sell or their price range. The filing also did not list underwriters. Slack is going public through a direct listing and will publicly offer shares of the company to anyone who wants to buy them on opening day, recode said. Slack said in the filing that listing its stock on the NYSE without underwriters “is a novel method for commencing public trading in shares of our Class A common stock, and consequently, the trading volume and price of shares of our Class A common stock may be more volatile than if shares of our Class A common stock were initially listed in connection with an underwritten initial public offering.” Slack is backed by Accel, Andreessen Horowitz, Social Capital and SoftBank.
1 min read · 29 April 2019